Crohn's Disease Market Future Prospects and Forecast To 2030
The report " Crohn’s Disease Market by Procedures (Colonoscopy, Flexible Sigmoidoscopy, Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), Capsule Endoscopy, Double-Balloon Endoscopy, Small Bowel Imaging), by Therapeutic Type (Non-surgical, Surgical), by End User (Hospitals and Clinics, Research Institutes, Diagnostic Centres and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online and Others), and Region - Global Forecasts to 2030", is projected to reach USD 10,923.4 million in 2023, having grown at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period 2024-2030 Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=204392 Competitive Dashboard: The prominent key players operating in the global crohn’s disease market are GlaxoSmithKline plc. Hoffmann-La Roche Ltd Novartis AG Eli Lilly and Company. Astrazeneca Pfizer Inc. Takeda Pharmaceutical Company Limited. Bristol-Myer...